Article
The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Current treatment options in oncology - 1 Oct 2016
Wirsching Hans-Georg, Weller Michael
Abstract excerpt
OPINION STATEMENT: The revised World Health Organization (WHO) classification of tumors of the central nervous system of 2016 combines biology-driven molecular marker diagnostics with classical histological cancer diagnosis. Reclassification of gliomas by molecular similarity beyond histological boundaries improves outcome prediction and will increasingly guide treatment decisions. This change in paradigms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
